This study investigates pancreatic cancer with liver oligometastases. The purpose of this study is to compare surgical resection with palliative care for patients with stable disease or response to chemotherapy.
The study evaluates the impact of these treatments on survival and quality of life. It focuses on assessing the safety and effectiveness of surgical intervention compared to ongoing palliative care.
- Who can participate: Adults aged 18 to 75 years with confirmed pancreatic adenocarcinoma and up to 3 liver metastases can participate. They must have stable disease or a partial response after chemotherapy and good performance status.
- Study details: Participants will either undergo surgery to remove the tumor and liver metastases or continue with palliative care, which may include chemotherapy.
- Study timelines: The study will last 2 years.
How understandable was the trial content above?
Hard to understand
Easy to understand